Silex (ASX:SLX) finishes world-first Q-Si plant aimed at a sub-50kg market

First 20kg of enriched silicon-28 lands in early 2027 and the uranium-only story quietly becomes a two-engine one

Silex Systems (ASX:SLX) has just told the market that construction of the world’s first laser-based silicon enrichment plant is finished, with commissioning now underway in Sydney. Sample production of highly enriched silicon-28 is scheduled for Q1 of calendar 2027.

Most of the market follows Silex for one reason. The uranium enrichment joint venture with Cameco, Global Laser Enrichment, sitting at the centre of the Western push to displace Russian enrichment capacity. That is still the headline story.

Today’s update matters because it adds a second commercial leg that has been quietly maturing in the background. The Quantum Silicon, or Q-Si, project is the same SILEX laser separation technology pointed at a different isotope, aimed at the substrates that silicon-based quantum computers will be built on.

The initial module is small. Up to 20kg per year against a global market currently under 50kg per year. But Silex is now positioning to be the only Western supplier of a material that quantum computing developers, semiconductor companies and hyperscalers will need if silicon-based qubits scale into commercial use later this decade.

Why a 20kg plant is more strategic than it sounds

Quantum Silicon is enriched silicon-28, the isotope used as a substrate to fabricate qubits. These are the building blocks of silicon-based quantum computers, the rough equivalent of transistors on a classical Nvidia or Intel chip but engineered at atomic scale.

Historically this material has come out of Russia using gas centrifuges, which is the same supply problem the West is trying to solve in uranium. Silex is essentially running the uranium playbook a second time on a different isotope, with the same geopolitical tailwind underneath it.

The 20kg figure looks modest until you remember the entire current market sits below 50kg per year. A single production module already covers a meaningful share of global demand, and Silex has flagged that modular expansion at a dedicated site is the path if demand scales.

The offtake question is the one investors should track

Silex has named Silicon Quantum Computing Pty Ltd as its first commercial offtake partner, with product qualification underway. Management also flagged increasing engagement with potential offshore customers and expects additional offtake agreements over the next year and beyond.

Our concern is that quantum computing commercialisation timelines have slipped before, and the announcement itself notes the first commercial machines are only expected by the end of the decade. Q-Si revenue therefore depends on third parties hitting their own roadmaps.

We think the more useful read is that Silex has built the supply infrastructure before the demand curve, which is the right sequence for a strategic material business. The risk is that the demand curve arrives later than the marketing decks suggest.

Where this sits in the broader Silex story

The uranium side has had a noisy 12 months. GLE hit Technology Readiness Level 6 validation in October 2025, secured a US$98.9 million incentives package from Kentucky for the Paducah facility, and joined the ASX 200 in the December rebalance. It also missed out on the larger US Department of Energy enrichment award, which knocked the stock 26% on the day.

Q-Si gives the investment case a second optionality leg that does not depend on US Department of Energy outcomes or the Paducah construction schedule. It is a smaller dollar opportunity in the near term, but a real one, and it runs on a different clock.

For a pre-profit company with roughly A$15 million in annual revenue, having two independent commercialisation tracks reduces the single-point-of-failure risk that has always haunted the SLX thesis.

The Investors Takeaway for Silex Systems

Construction done is a real milestone. The harder bits, commissioning the laser system, integrating the first two enrichment reactors, and getting sample-grade silicon-28 into customers’ hands in Q1 2027, are still in front of management.

We would want to see at least one additional offtake partner signed before Q-Si starts showing up as a serious valuation input. Until then, the uranium story remains the dominant driver of the share price and Q-Si is best treated as embedded optionality, not the base case.

Investors can read our previous coverage of the uranium side of this story at stocksdownunder, where we worked through the Paducah economics in more detail.